The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network
Caroline Voskens(Friedrich-Alexander-Universität Erlangen-Nürnberg), Lucie Heinzerling(LMU Klinikum)
Cited by 470
Related Papers
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
|Journal of the American College of Cardiology|2018|1.5k
Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy
|Journal for ImmunoTherapy of Cancer|2016|510
Skin cancer classification via convolutional neural networks: systematic review of studies involving human experts
|European Journal of Cancer|2021|246
Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV600E inhibition in melanoma
|European Journal of Cancer|2019|26